• Je něco špatně v tomto záznamu ?

Predictive relevance of miR-34a, miR-224 and miR-342 in patients with advanced squamous cell carcinoma of the lung undergoing palliative chemotherapy

V. Kulda, M. Svaton, P. Mukensnabl, K. Hrda, P. Dvorak, Z. Houdek, K. Houfkova, R. Vrzakova, V. Babuska, M. Pesek, M. Pesta,

. 2018 ; 15 (1) : 592-599. [pub] 20171102

Jazyk angličtina Země Řecko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18010035

Attributing to their pathophysiological role and stability in biological samples, microRNAs (miRNAs) have the potential to become valuable predictive markers for non-small cell lung cancer (NSCLC). Samples of biopsy tissue constitute suitable material for miRNA profiling with the aim of predicting the effect of palliative chemotherapy. The present study group included 81 patients (74 males, 7 females, all smokers or former smokers) with the squamous cell carcinoma (SCC) histological subtype of NSCLC at a late stage (3B or 4). All patients received palliative chemotherapy based on platinum derivatives in combination with paclitaxel or gemcitabine. The expression of 17 selected miRNAs was measured by reverse transcription-quantitative polymerase chain reaction in tumor tissue macrodissected from formalin-fixed paraffin-embedded (FFPE) tissue samples. To predict the effect of palliative chemotherapy, the association between gene expression levels and overall survival (OS) time was analyzed. From the 17 miRNAs of interest, low expression levels of miR-342 and high expression levels of miR-34a and miR-224 were associated with a reduced OS time in subgroups of patients based on smoking status and treatment modality. Using cluster analysis, associations between combinations of miR-34a, -224 and -342 expression levels with patient survival were identified. The present study revealed that patients with the simultaneous high expression of miR-224 and -342 had a similar prognostic outcome to those with the low expression of miR-224 and -342, which was significantly reduced, compared with patients exhibiting high expression of either miR-224 or miR-342 with low expression of the other. We hypothesize that the effect of a particular miRNA is dependent on the expression level of other members of the miRNA network. This finding appears to complicate survival analyses based on individual miRNAs as markers. In conclusion, the present study provides evidence that specific miRNAs were associated with OS time, which may be candidate predictors for the effectiveness of palliative treatment in SCC lung cancer patients. This objective can be better achieved by combining more markers together than by using individual miRNAs.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18010035
003      
CZ-PrNML
005      
20180511122735.0
007      
ta
008      
180404s2018 gr f 000 0|eng||
009      
AR
024    7_
$a 10.3892/ol.2017.7337 $2 doi
035    __
$a (PubMed)29387235
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gr
100    1_
$a Kulda, Vlastimil $u Department of Medical Chemistry and Biochemistry, Faculty of Medicine in Pilsen, Charles University, 30166 Pilsen, Czech Republic.
245    10
$a Predictive relevance of miR-34a, miR-224 and miR-342 in patients with advanced squamous cell carcinoma of the lung undergoing palliative chemotherapy / $c V. Kulda, M. Svaton, P. Mukensnabl, K. Hrda, P. Dvorak, Z. Houdek, K. Houfkova, R. Vrzakova, V. Babuska, M. Pesek, M. Pesta,
520    9_
$a Attributing to their pathophysiological role and stability in biological samples, microRNAs (miRNAs) have the potential to become valuable predictive markers for non-small cell lung cancer (NSCLC). Samples of biopsy tissue constitute suitable material for miRNA profiling with the aim of predicting the effect of palliative chemotherapy. The present study group included 81 patients (74 males, 7 females, all smokers or former smokers) with the squamous cell carcinoma (SCC) histological subtype of NSCLC at a late stage (3B or 4). All patients received palliative chemotherapy based on platinum derivatives in combination with paclitaxel or gemcitabine. The expression of 17 selected miRNAs was measured by reverse transcription-quantitative polymerase chain reaction in tumor tissue macrodissected from formalin-fixed paraffin-embedded (FFPE) tissue samples. To predict the effect of palliative chemotherapy, the association between gene expression levels and overall survival (OS) time was analyzed. From the 17 miRNAs of interest, low expression levels of miR-342 and high expression levels of miR-34a and miR-224 were associated with a reduced OS time in subgroups of patients based on smoking status and treatment modality. Using cluster analysis, associations between combinations of miR-34a, -224 and -342 expression levels with patient survival were identified. The present study revealed that patients with the simultaneous high expression of miR-224 and -342 had a similar prognostic outcome to those with the low expression of miR-224 and -342, which was significantly reduced, compared with patients exhibiting high expression of either miR-224 or miR-342 with low expression of the other. We hypothesize that the effect of a particular miRNA is dependent on the expression level of other members of the miRNA network. This finding appears to complicate survival analyses based on individual miRNAs as markers. In conclusion, the present study provides evidence that specific miRNAs were associated with OS time, which may be candidate predictors for the effectiveness of palliative treatment in SCC lung cancer patients. This objective can be better achieved by combining more markers together than by using individual miRNAs.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Svatoň, Martin $u Department of Pneumology and Phthisiology, Faculty of Medicine in Pilsen, Charles University, 30166 Pilsen, Czech Republic. $7 xx0224192
700    1_
$a Mukensnabl, Petr $u Department of Pathology, Faculty of Medicine in Pilsen, Charles University, 30166 Pilsen, Czech Republic.
700    1_
$a Hrda, Kristyna $u Department of Medical Chemistry and Biochemistry, Faculty of Medicine in Pilsen, Charles University, 30166 Pilsen, Czech Republic. Department of Pneumology and Phthisiology, Faculty of Medicine in Pilsen, Charles University, 30166 Pilsen, Czech Republic.
700    1_
$a Dvorak, Pavel $u Department of Biology, Faculty of Medicine in Pilsen, Charles University, 30166 Pilsen, Czech Republic.
700    1_
$a Houdek, Zbynek $u Department of Biology, Faculty of Medicine in Pilsen, Charles University, 30166 Pilsen, Czech Republic.
700    1_
$a Houfkova, Katerina $u Department of Biology, Faculty of Medicine in Pilsen, Charles University, 30166 Pilsen, Czech Republic.
700    1_
$a Vrzakova, Radana $u Department of Medical Chemistry and Biochemistry, Faculty of Medicine in Pilsen, Charles University, 30166 Pilsen, Czech Republic.
700    1_
$a Babuska, Vaclav $u Department of Medical Chemistry and Biochemistry, Faculty of Medicine in Pilsen, Charles University, 30166 Pilsen, Czech Republic.
700    1_
$a Pesek, Milos $u Department of Pneumology and Phthisiology, Faculty of Medicine in Pilsen, Charles University, 30166 Pilsen, Czech Republic.
700    1_
$a Pesta, Martin $u Department of Biology, Faculty of Medicine in Pilsen, Charles University, 30166 Pilsen, Czech Republic. Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, 30166 Pilsen, Czech Republic.
773    0_
$w MED00193499 $t Oncology letters $x 1792-1074 $g Roč. 15, č. 1 (2018), s. 592-599
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29387235 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180404 $b ABA008
991    __
$a 20180511122907 $b ABA008
999    __
$a ind $b bmc $g 1287520 $s 1006847
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 15 $c 1 $d 592-599 $e 20171102 $i 1792-1074 $m Oncology letters $n Oncol Lett $x MED00193499
LZP    __
$a Pubmed-20180404
Zpět

Najít záznam

Citační ukazatele

Možnosti archivace